Christopher Bunka - Net Worth and Insider Trading

Christopher Bunka Net Worth

The estimated net worth of Christopher Bunka is at least $2 Million dollars as of 2024-03-28. Christopher Bunka is the CEO of Lexaria Bioscience Corp and owns about 489,455 shares of Lexaria Bioscience Corp (LEXX) stock worth over $2 Million. Christopher Bunka is also the 10% Owner of Enertopia Corp and owns about 3,707,833 shares of Enertopia Corp (ENRT) stock worth over $73,786. Details can be seen in Christopher Bunka's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christopher Bunka has not made any transactions after 2022-10-13 and currently still holds the listed stock(s).

Transaction Summary of Christopher Bunka

To

Christopher Bunka Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher Bunka owns 2 companies in total, including Lexaria Bioscience Corp () , and Enertopia Corp () .

Click here to see the complete history of Christopher Bunka’s form 4 insider trades.

Insider Ownership Summary of Christopher Bunka

Ticker Comapny Transaction Date Type of Owner
Lexaria Bioscience Corp 2022-10-13 director & 10 percent owner & CEO
Enertopia Corp 2013-08-28 director & Chairman and CEO

Christopher Bunka Latest Holdings Summary

Christopher Bunka currently owns a total of 2 stocks. Among these stocks, Christopher Bunka owns 489,455 shares of Lexaria Bioscience Corp (LEXX) as of October 13, 2022, with a value of $2 Million and a weighting of 96.01%. Christopher Bunka also owns 3,707,833 shares of Enertopia Corp (ENRT) as of August 28, 2013, with a value of $73,786 and a weighting of 3.99%.

Latest Holdings of Christopher Bunka

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LEXX Lexaria Bioscience Corp 2022-10-13 489,455 3.63 1,776,722
ENRT Enertopia Corp 2013-08-28 3,707,833 0.02 73,786

Holding Weightings of Christopher Bunka


Christopher Bunka Form 4 Trading Tracker

According to the SEC Form 4 filings, Christopher Bunka has made a total of 2 transactions in Lexaria Bioscience Corp (LEXX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Lexaria Bioscience Corp is the acquisition of 38,500 shares on October 13, 2022, which cost Christopher Bunka around $78,540.

According to the SEC Form 4 filings, Christopher Bunka has made a total of 0 transactions in Enertopia Corp (ENRT) over the past 5 years. The most-recent trade in Enertopia Corp is the acquisition of 274,000 shares on August 28, 2013, which cost Christopher Bunka around $5,480.

Insider Trading History of Christopher Bunka

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Christopher Bunka Trading Performance

GuruFocus tracks the stock performance after each of Christopher Bunka's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher Bunka is 16.06%. GuruFocus also compares Christopher Bunka's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher Bunka within 3 months outperforms 68 times out of 115 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Christopher Bunka's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Christopher Bunka

Average Relative Return

47.46%

Average relative return per transaction

Outperforming Transactions

58%

75 out of 130 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 13.22 16.06 53.41 47.46 85.98 69.16
Relative Return to S&P 500(%) 13.47 16.12 51.28 40.42 74.34 57.7

Christopher Bunka Ownership Network

Ownership Network List of Christopher Bunka

No Data

Ownership Network Relation of Christopher Bunka


Christopher Bunka Owned Company Details

What does Lexaria Bioscience Corp do?

Who are the key executives at Lexaria Bioscience Corp?

Christopher Bunka is the director & 10 percent owner & CEO of Lexaria Bioscience Corp. Other key executives at Lexaria Bioscience Corp include Chief Financial Officer Gregory Downey , Secretary Vanessa Carle , and CFO Allan Horst Spissinger .

Lexaria Bioscience Corp () Insider Trades Summary

Over the past 18 months, Christopher Bunka made 1 insider transaction in Lexaria Bioscience Corp () with a net purchase of 38,500. Other recent insider transactions involving Lexaria Bioscience Corp () include a net purchase of 1,500 shares made by Catherine C. Turkel , a net purchase of 121 shares made by Gregory Downey ,

In summary, during the past 3 months, insiders sold 0 shares of Lexaria Bioscience Corp () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lexaria Bioscience Corp () were sold and 40,121 shares were bought by its insiders, resulting in a net purchase of 40,121 shares.

Lexaria Bioscience Corp ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Lexaria Bioscience Corp Insider Transactions

No Available Data

Christopher Bunka Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher Bunka. You might contact Christopher Bunka via mailing address: 1924 Birkdale Ave, Kelowna A1 V1p1r7.

Discussions on Christopher Bunka

No discussions yet.